Merck & Co., Inc. — 13F Holdings

2026 Q3  ·  13 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Merck & Co., Inc. maintained a portfolio of 13 distinct positions.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
13
Quarter
2026 Q3
Top Holding
MRNA (54.2%)
Top 10 Concentration
99.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13

Merck & Co., Inc. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
MRNA
MODERNA INC
Healthcare 54.18% 30.71% #1 1
Prev: #2
7.0
—
no change no change
P
S
2,308,190 $444,488,148
$41.58 +379.4%
$192.57 +3.5%
2024 Q4 13F Filing 2026-09-30 2026-11-13
PSNL
PERSONALIS INC
Healthcare 27.87% 35.75% #2 1
Prev: #1
6.5
—
no change no change
P
S
14,044,943 $228,651,672
$5.78 +146.9%
$16.28 -12.3%
2024 Q4 13F Filing 2026-09-30 2026-11-13
KYMR
KYMERA THERAPEU...
Healthcare 10.52% 16.82% #3
Prev: #3
6.0
—
no change no change
P
S
772,165 $86,320,325
$40.23 +186.6%
$111.79 +3.1%
2024 Q4 13F Filing 2026-09-30 2026-11-13
AKTS
AKTIS ONCOLOGY ...
Healthcare 2.26% 5.83% #4
Prev: #4
2.4
—
no change no change
P
S
952,844 $18,551,873 2026 Q1 13F Filing 2026-09-30 2026-11-13
EIKN
EIKON THERAPEUT...
Healthcare 1.63% 4.13% #5
Prev: #5
2.2
—
no change no change
P
S
1,666,666 $13,399,995 2026 Q1 13F Filing 2026-09-30 2026-11-13
TRDA
ENTRADA THERAPE...
Healthcare 1.35% 2.43% #6
Prev: #6
1.5
—
no change no change
P
S
1,739,768 $11,047,527 2026 Q2 13F Filing 2026-09-30 2026-11-13
ALEC
ALECTOR INC
Healthcare 0.80% 1.35% #7 1
Prev: #8
1.3
—
no change no change
P
S
3,545,719 $6,559,581 2024 Q4 13F Filing 2026-09-30 2026-11-13
STRO
SUTRO BIOPHARMA...
Healthcare 0.53% 1.72% #8 1
Prev: #7
1.2
—
no change no change
P
S
272,351 $4,387,575 2024 Q4 13F Filing 2026-09-30 2026-11-13
EVAX
EVAXION AS
Healthcare 0.49% 0.71% #9
Prev: #9
1.2
—
no change no change
P
S
1,214,126 $3,982,333 2024 Q4 13F Filing 2026-09-30 2026-11-13
VRDN
VIRIDIAN THERAP...
Healthcare 0.23% 0.33% #10
Prev: #10
1.1
—
no change no change
P
S
93,414 $1,923,394 2024 Q4 13F Filing 2026-09-30 2026-11-13
XLO
XILIO THERAPEUT...
Healthcare 0.12% 0.19% #11
Prev: #11
1.0
—
no change no change
P
S
105,982 $959,137 2024 Q4 13F Filing 2026-09-30 2026-11-13
HURA
TUHURA BIOSCIEN...
Healthcare 0.00% 0.01% #12
Prev: #12
1.0
—
no change no change
P
S
19,445 $40,834 2025 Q2 13F Filing 2026-09-30 2026-11-13
NEUP
NEUPHORIA THERA...
Healthcare 0.00% 0.01% #13
Prev: #13
1.0
—
no change no change
P
S
10,027 $35,696 2024 Q4 13F Filing 2026-09-30 2026-11-13
Showing 1-13 of 13 holdings

Unlock Full Merck & Co., Inc. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →